Cargando…
New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae
5-Flucytosine is currently used as an antifungal drug in combination therapy, but fungal pathogens are rapidly able to develop resistance against this drug, compromising its therapeutic action. The understanding of the underlying resistance mechanisms is crucial to deal with this problem. In this wo...
Autores principales: | Costa, Catarina, Ponte, Andreia, Pais, Pedro, Santos, Rui, Cavalheiro, Mafalda, Yaguchi, Takashi, Chibana, Hiroji, Teixeira, Miguel Cacho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534419/ https://www.ncbi.nlm.nih.gov/pubmed/26267134 http://dx.doi.org/10.1371/journal.pone.0135110 |
Ejemplares similares
-
Membrane Proteomics Analysis of the Candida glabrata Response to 5-Flucytosine: Unveiling the Role and Regulation of the Drug Efflux Transporters CgFlr1 and CgFlr2
por: Pais, Pedro, et al.
Publicado: (2016) -
Screening the Drug:H(+) Antiporter Family for a Role in Biofilm Formation in Candida glabrata
por: Santos, Rui, et al.
Publicado: (2020) -
A New Determinant of Candida glabrata Virulence: The Acetate Exporter CgDtr1
por: Romão, Daniela, et al.
Publicado: (2017) -
Role of CgTpo4 in Polyamine and Antimicrobial Peptide Resistance: Determining Virulence in Candida glabrata
por: Cavalheiro, Mafalda, et al.
Publicado: (2021) -
A Transcriptomics Approach To Unveiling the Mechanisms of In Vitro Evolution towards Fluconazole Resistance of a Candida glabrata Clinical Isolate
por: Cavalheiro, Mafalda, et al.
Publicado: (2018)